Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Efavirenz”

298 trials

Showing 20 of 298 results

Testing effectiveness (Phase 2)Study completedNCT01338883
What this trial is testing

Efficacy, Safety, and Tolerability of Cenicriviroc (CVC) in Combination With Truvada or Sustiva Plus Truvada in HIV 1-infected, Antiretroviral Treatment-naïve, Adult Patients Infected With Only CCR5-tropic Virus

Who this might be right for
HIV-1 Infection
Tobira Therapeutics, Inc. 143
Testing effectiveness (Phase 2)Study completedNCT00002239
What this trial is testing

Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected Adults

Who this might be right for
HIV Infections
Hoffmann-La Roche 68
Early research (Phase 1)Study completedNCT01479361
What this trial is testing

Antiretroviral Drug Interaction Study in Volunteers With HIV

Who this might be right for
HIVPCPToxoplasmosis
National Institutes of Health Clinical Center (CC) 36
Post-approval studies (Phase 4)Ended earlyNCT00765154
What this trial is testing

NNRTI/PI Toxicity Switch to Darunavir Study

Who this might be right for
HIV
St Stephens Aids Trust 12
Early research (Phase 1)Study completedNCT00162097
What this trial is testing

Pharmacokinetics of Efavirenz in HIV-1 Infected Subjects With Hepatic Impairment

Who this might be right for
HIV InfectionsHepatic Impairment
Bristol-Myers Squibb 21
Large-scale testing (Phase 3)Study completedNCT00002393
What this trial is testing

Indinavir Taken With or Without DMP 266

Who this might be right for
HIV Infections
Dupont Merck 300
Large-scale testing (Phase 3)Study completedNCT02670772
What this trial is testing

Dose Optimisation of Stavudine for the Treatment of HIV Infection

Who this might be right for
Acquired Immune Deficiency SyndromeHuman Immunodeficiency Virus
Willem Daniel Francois Venter 1,077
Large-scale testing (Phase 3)Study completedNCT02777229
What this trial is testing

Efficacy and Safety of a Dolutegravir-based Regimen for the Initial Management of HIV Infected Adults in Resource-limited Settings

Who this might be right for
HIV-1 Infection
ANRS, Emerging Infectious Diseases 616
Early research (Phase 1)Study completedNCT01571414
What this trial is testing

Evaluating the Safety and Drug Interaction of PA-824, an Investigational Tuberculosis Medication, Together With Efavirenz, Ritonavir-Boosted Lopinavir, or Rifampin

Who this might be right for
Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 52
Testing effectiveness (Phase 2)Study completedNCT00038532
What this trial is testing

Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subjects Following Failure With Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAART

Who this might be right for
HIV Infections
Abbott 24
Post-approval studies (Phase 4)Ended earlyNCT01194856
What this trial is testing

Switching From Efavirenz to Atazanavir/ Ritonavir in HIV-infected Subjects With Good Virologic Suppression

Who this might be right for
HIV InfectionMitochondrial Dysfunction
The Cleveland Clinic 1
Large-scale testing (Phase 3)Study completedNCT00158457
What this trial is testing

Simple Once Daily Triple Regimen Including Tenofovir, Emtricitabine and Efavirenz in HIV-1 Infected Patients (ANRS 1207)

Who this might be right for
HIV Infection
French National Agency for Research on AIDS and Viral Hepatitis 40
Testing effectiveness (Phase 2)Study completedNCT00869557
What this trial is testing

Study of the Safety and Efficacy of Stribild Versus Atripla in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults

Who this might be right for
HIVHIV Infections
Gilead Sciences 71
Post-approval studies (Phase 4)Study completedNCT02945163
What this trial is testing

Dosing of Tenofovir and Efavirenz in Antiretroviral Therapy

Who this might be right for
HIV Infections
Shanghai Public Health Clinical Center 184
Not applicableStudy completedNCT03336346
What this trial is testing

Effect of Dolutegravir on Etonogestrel Levels in HIV-infected Women in Botswana

Who this might be right for
Contraceptive UsageHIV InfectionsDrug Interaction
Columbia University 148
Post-approval studies (Phase 4)Study completedNCT00299091
What this trial is testing

Modification of Doses of Efavirenz According to Its Blood Concentration in HIV Patients

Who this might be right for
HIV
Germans Trias i Pujol Hospital 31
Testing effectiveness (Phase 2)Study completedNCT00001122
What this trial is testing

An Adherence Plan to Help HIV-Positive Patients Take Their First Anti-HIV Medications Correctly

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 74
Large-scale testing (Phase 3)Study completedNCT01271894
What this trial is testing

The Intensive Pharmacokinetics Sub-study of Encore1 (ENCORE1-PK)

Who this might be right for
HIV Infection
Kirby Institute 40
Not applicableUnknownNCT01315301
What this trial is testing

Optimal Time to Initiate Antiretroviral Therapy in HIV & TB Coinfected Adults Being Treated for Tuberculosis

Who this might be right for
Acquired Immunodeficiency SyndromeTuberculosis
Karolinska Institutet 450
Not applicableWithdrawnNCT03405194
What this trial is testing

Same-Day Treatment With Genvoya vs. EFV/TDF/3TC

Who this might be right for
HIV/AIDS
Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation